Cardiovascular effects of epinephrine and dipivalyl epinephrine applied topically to the eye in patients with glaucoma.

Author: DranceS M, HassI, KerrC R, SchulzerM, WaltersM B

Paper Details 
Original Abstract of the Article :
The cardiovascular effects of topical ophthalmological preparations of 2% epinephrine (EPI), 0.1% dipivalyl epinephrine (DPE), and placebo were studied in double-blind fashion in 20 patients with glaucoma. Both drugs and placebo produced a decrease in heart rate (2 +/- 3 beats/min) which, although s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/bjo.66.2.109

データ提供:米国国立医学図書館(NLM)

Epinephrine and Dipivalyl Epinephrine: Navigating the Cardiovascular Landscape of Glaucoma Treatment

Glaucoma, a leading cause of irreversible vision loss, often requires topical medications to lower intraocular pressure. Epinephrine and its analog, dipivalyl epinephrine (DPE), are commonly used for this purpose. However, concerns about their potential cardiovascular side effects have prompted researchers to investigate their impact on heart rate and blood pressure. This study aimed to compare the cardiovascular effects of epinephrine and DPE, administered topically to the eye, in patients with glaucoma.

Epinephrine: A Potential for Cardiovascular Side Effects

The study found that both epinephrine and DPE caused a slight but significant decrease in heart rate. However, epinephrine, unlike DPE, led to a significant increase in mean or systolic blood pressure in a subset of patients. These findings suggest that epinephrine, while effective in managing glaucoma, may pose a greater risk of cardiovascular side effects for some individuals. This study highlights the importance of careful patient selection and monitoring for potential cardiovascular complications when using epinephrine for glaucoma treatment.

Treating Glaucoma: A Balance of Benefits and Risks

Glaucoma treatment requires a careful balance between the benefits of lowering intraocular pressure and the potential risks associated with medication. This study underscores the need for a personalized approach, considering individual patient factors and potential cardiovascular risks. Just as a desert traveler must choose their path carefully, healthcare providers should weigh the potential benefits and risks of different glaucoma medications before making treatment decisions.

Dr.Camel's Conclusion

This study is like a desert oasis, offering respite from the harsh realities of glaucoma treatment. While epinephrine can be effective, we must be aware of its potential for cardiovascular side effects. Like a wise desert traveler, we must be vigilant and adapt our approach based on the individual needs of each patient. Remember, the journey to preserving vision requires a careful balance of knowledge, compassion, and careful monitoring.

Date :
  1. Date Completed 1982-05-27
  2. Date Revised 2019-05-01
Further Info :

Pubmed ID

7037047

DOI: Digital Object Identifier

10.1136/bjo.66.2.109

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.